Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F6Y1R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,336
Award facts
- Contract value 100% obligated
- $14,335.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,335.60 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of January 28, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. REPATHA (evolocumab) is a PCSK9 inhibitor used to treat high cholesterol, and the auto-injector delivery mechanism ensures convenient administration for patients requiring this specialty pharmaceutical.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion vehicle designated SPE2DX that extends through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary IDC arrangement and serves as a critical pharmaceutical vendor supporting military healthcare programs globally. Through this comprehensive contract vehicle, AmerisourceBergen supplies specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's federal procurement portfolio demonstrates its established capability to meet government medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F6Y1R?
SPE2DR26F6Y1R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F6Y1R worth?
The government has obligated $14,336 on SPE2DR26F6Y1R.
Is contract SPE2DR26F6Y1R an order under another contract?
Yes. SPE2DR26F6Y1R is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6Y1R competed?
The extent of competition for SPE2DR26F6Y1R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award